Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5402)
All Articles published online
|
Mar 21, 2011 (publication date) through Oct 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yan SY, Hu Y, Fan JG, Tao GQ, Lu YM, Cai X, Yu BH, Du YQ. Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma. World J Gastroenterol 2011; 17(11): 1501-1506 [PMID: 21472111 DOI: 10.3748/wjg.v17.i11.1501] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i11/1501.htm |
| Number | Citing Articles |
| 1 |
Yu-ying Lei, Jin-yu Huang, Qiong-rui Zhao, Nan Jiang, Hui-mian Xu, Zhen-ning Wang, Hai-qing Li, Shi-bo Zhang, Zhe Sun. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature. World Journal of Surgical Oncology 2017; 15(1) doi: 10.1186/s12957-017-1132-5
|
| 2 |
XR Hu, YX Hu, HR Fu, LX Sheng, WJ Huang, KY Hu, H Huang, WZ Xie. Diffuse Large B-Cell Lymphoma with Concurrent Gastric Adenocarcinoma: Case Report and Literature Review. Journal of International Medical Research 2011; 39(5): 2051 doi: 10.1177/147323001103900554
|
| 3 |
Zong-Qiong Sun, Yu-Xi Ge, Lin Chen, Jie Li, Lin-Fang Jin, Zhi-Hui Xie. The feasibility of low-dose CT perfusion imaging in gastric cancer. Journal of X-Ray Science and Technology 2017; 25(5): 847 doi: 10.3233/XST-17282
|
| 4 |
Jennifer Jeung, Roshan Patel, Lizette Vila, Dara Wakefield, Chen Liu. Quantitation of HER2/neu Expression in Primary Gastroesophageal Adenocarcinomas Using Conventional Light Microscopy and Quantitative Image Analysis. Archives of Pathology & Laboratory Medicine 2012; 136(6): 610 doi: 10.5858/arpa.2011-0371-OA
|
| 5 |
Nobumitsu Shiina, Atsushi Okuno, Yasuo Wakabayashi, Hisao Koshikawa. A Complete Response Case of Gastric Cancer to Intravenous and Intraperitoneal Paclitaxel Combined with S-1 and Trastuzumab. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) 2013; 38(2): 307 doi: 10.4030/jjcs.38.307
|
| 6 |
Duminda Subasinghe, Nathan Acott, Pasyodun Koralage Buddhika Mahesh, Sivasuriya Sivaganesh, Sithum Munasinghe, Mariyan Priyanthi Kumarasinghe, Dharmabandu Nandaveva Samarasekera, Menaka Dilani Samarawickrema Lokuhetty. Human epidermal growth factor receptor-2 gene expression positivity determined by silver in situ hybridization/immunohistochemistry methods and associated factors in a cohort of Sri Lankan patients with gastric adenocarcinoma: a prospective study. Journal of International Medical Research 2023; 51(2): 030006052311544 doi: 10.1177/03000605231154403
|
| 7 |
Seyed-Hamid Madani, Ali Rahmati, Edris Sadeghi, Sedighe Khazaei, Masoud Sadeghi, Mehrdad Payandeh, Nasrin Amirifard. Survey of Her2-neu Expression and its Correlation with Histology of Gastric Carcinoma and Gastroesophageal Junction Adenocarcinoma. Asian Pacific Journal of Cancer Prevention 2015; 16(17): 7755 doi: 10.7314/APJCP.2015.16.17.7755
|
| 8 |
J. S. Sukanya, Pavithra Vittal Raj, J. Thanka. Role of HER2neu expression in gastric cancer. Indian Journal of Pathology and Microbiology 2021; 64(1): 58 doi: 10.4103/IJPM.IJPM_835_19
|
| 9 |
Sang-Woo Lim, Hye-Ran Kim, Hwan-Young Kim, Jung-Wook Huh, Young-Jin Kim, Jong-Hee Shin, Soon-Pal Suh, Dong-Wook Ryang, Hyeong-Rok Kim, Myung-Geun Shin. Over-expression of Her-2 in colorectal cancer tissue, but not in serum, constitutes an independent worse prognostic factor. Cellular Oncology 2013; 36(4): 311 doi: 10.1007/s13402-013-0136-6
|
| 10 |
Zongqiong Sun, Xiaofang Cheng, Yuxi Ge, Lin Shao, Yinghua Xuan, Gen Yan. An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma. Gastric Cancer 2018; 21(3): 413 doi: 10.1007/s10120-017-0763-0
|
| 11 |
Abhilash V. B., Manas Kumar Behera, Shashikant C. U. Patne, Sunit Kumar Shukla, Vinod Kumar Dixit. Clinicopathological Significance and Prognostic Role of Her2neu Protein Expression in Patients with Carcinoma Stomach: A Prospective Study from Northern India. South Asian Journal of Cancer 2023; 12(02): 135 doi: 10.1055/s-0042-1759601
|
| 12 |
Fang Li, Guiqing Meng, Bibo Tan, Zihao Chen, Qiang Ji, Xiaoxiao Wang, Chang Liu, Shuyao Niu, Yong Li, Yueping Liu. Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis. Pathology - Research and Practice 2021; 217: 153280 doi: 10.1016/j.prp.2020.153280
|
| 13 |
G. Jomrich, S. F. Schoppmann. Targeted therapy in gastric cancer. European Surgery 2016; 48(5): 278 doi: 10.1007/s10353-016-0389-1
|
| 14 |
Maria McIntire, Mark Redston. Targeted Therapies and Predictive Markers in Epithelial Malignancies of the Gastrointestinal Tract. Archives of Pathology & Laboratory Medicine 2012; 136(5): 496 doi: 10.5858/arpa.2011-0167-RA
|
| 15 |
Toshihiro Tajirika, Yoshihisa Tokumaru, Kohei Taniguchi, Nobuhiko Sugito, Nobuhisa Matsuhashi, Manabu Futamura, Kazuyoshi Yanagihara, Yukihiro Akao, Kazuhiro Yoshida. DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer Cells. International Journal of Molecular Sciences 2018; 19(7): 2005 doi: 10.3390/ijms19072005
|
| 16 |
Li-Hua Jiang, Ying-Li Hao, Jing-Wei Zhu. Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2019; 43(3): 282 doi: 10.1016/j.clinre.2018.09.011
|
| 17 |
Dominique Werner, Achim Battmann, Kristina Steinmetz, Tobin Jones, Tiffany Lamb, Michele Martinez, Hans-Michael Altmannsberger, Salah-Eddin Al-Batran. The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing. Journal of Translational Medicine 2014; 12(1): 160 doi: 10.1186/1479-5876-12-160
|
| 18 |
Y. Wang, L. He, Y. Cheng. An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis. Clinical and Translational Oncology 2018; 20(2): 212 doi: 10.1007/s12094-017-1711-5
|
| 19 |
Xiaoyan Liu, Xiaoling Wang, Bo Wang, Guoping Ren, Wei Ding. HER2 Gene Amplification by Fluorescence In Situ Hybridization (FISH) Compared With Immunohistochemistry (IHC) in 122 Equivocal Gastric Cancer Cases. Applied Immunohistochemistry & Molecular Morphology 2016; 24(7): 459 doi: 10.1097/PAI.0000000000000219
|
| 20 |
Ahmed Abdel Hadi, Ali El Hindawi, Amal Hareedy, Heba Khalil, Ranya Al Ashiry, Shady Elia, Ahmed Sadek, Mona Magdy, Rafatt Atta, Amgad Anas, Hisham Bakr, Olfat Hammam. Her2/neu Protein Expression and Oncogene Amplification in Gastric Carcinoma with Clinico-Pathological Correlation in Egyptian Patients. Open Access Macedonian Journal of Medical Sciences 2016; 4(4): 535 doi: 10.3889/oamjms.2016.104
|
| 21 |
Daisuke Kotani, Kohei Shitara. Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancer. Therapeutic Advances in Medical Oncology 2021; 13 doi: 10.1177/1758835920986518
|
| 22 |
Kan Wang, Jing Ruan, Qirong Qian, Hua Song, Chenchen Bao, Xueqing Zhang, Yifei Kong, Chunlei Zhang, Guohan Hu, Jian Ni, Daxiang Cui. BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer. Journal of Nanobiotechnology 2011; 9(1) doi: 10.1186/1477-3155-9-23
|
| 23 |
Arnaldo N. S. Silva, Jordy Coffa, Varsha Menon, Lindsay C. Hewitt, Kakoli Das, Yohei Miyagi, Dan Bottomley, Hayley Slaney, Toru Aoyama, Wolfram Mueller, Tomio Arai, Iain B. Tan, Niantao Deng, Xiu B. Chan, Patrick Tan, Akira Tsuburaya, Kentaro Sakamaki, Jeremy D. Hayden, Takaki Yoshikawa, Ilse Zondervan, Suvi Savola, Heike I. Grabsch. Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis. Annals of Surgery 2018; 267(1): 114 doi: 10.1097/SLA.0000000000002042
|
| 24 |
Hala M. El Hanbuli, Samar Ibrahim Ismail Amer, Heba A. Ibrahim. Expression of Septin 2 and Her2/neu in Colorectal Cancer. Journal of Microscopy and Ultrastructure 2022; 10(4): 197 doi: 10.4103/jmau.jmau_38_21
|
| 25 |
Kwang Kuk Park, Song I Yang, Kyung Won Seo, Ki Young Yoon, Sang Ho Lee, Hee Kyung Jang, Yeon Myeong Shin. Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative Resection. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/946359
|
| 26 |
Keishiro Aoyagi, Kikuo Kouhuji, Junya Kizaki, Taro Isobe, Kousuke Hashimoto, Kazuo Shirouzu. Molecular targeting to treat gastric cancer. World Journal of Gastroenterology 2014; 20(38): 13741-13755 doi: 10.3748/wjg.v20.i38.13741
|
| 27 |
Nicola Carlomagno, Paola Incollingo, Vincenzo Tammaro, Gaia Peluso, Niccolò Rupealta, Gaetano Chiacchio, Maria Laura Sandoval Sotelo, Gianluca Minieri, Antonio Pisani, Eleonora Riccio, Massimo Sabbatini, Umberto Marcello Bracale, Armando Calogero, Concetta Anna Dodaro, Michele Santangelo. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/7869802
|
| 28 |
M. Pirrelli, M. L. Caruso, M. Di Maggio, R. Armentano, A. M. Valentini. Are Biopsy Specimens Predictive of HER2 Status in Gastric Cancer Patients?. Digestive Diseases and Sciences 2012; doi: 10.1007/s10620-012-2357-3
|
| 29 |
Feng‐Hua Wang, Lin Shen, Jin Li, Zhi‐Wei Zhou, Han Liang, Xiao‐Tian Zhang, Lei Tang, Yan Xin, Jing Jin, Yu‐Jing Zhang, Xiang‐Lin Yuan, Tian‐Shu Liu, Guo‐Xin Li, Qi Wu, Hui‐Mian Xu, Jia‐Fu Ji, Yuan‐Fang Li, Xin Wang, Shan Yu, Hao Liu, Wen‐Long Guan, Rui‐Hua Xu. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Communications 2019; 39(1): 1 doi: 10.1186/s40880-019-0349-9
|
| 30 |
Yoshiki Kataoka, Hiroshi Okabe, Akihiko Yoshizawa, Sachiko Minamiguchi, Kenichi Yoshimura, Hironori Haga, Yoshiharu Sakai. HER2 expression and its clinicopathological features in resectable gastric cancer. Gastric Cancer 2013; 16(1): 84 doi: 10.1007/s10120-012-0150-9
|
| 31 |
Hai Cui, Ying Cheng, Su-Zhou Piao, Yun-Jie Xu, Hong-Hua Sun, Xian Cui, Xiang-Zi Li, Song-Nan Zhang, Long-Zhen Piao, Yong-Min Jin, Zhen-hua Lin, Xiong-Hu Shen. Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines. Cancer Cell International 2014; 14(1) doi: 10.1186/1475-2867-14-10
|
| 32 |
Sun Zongqiong, Li Xiaohong, Cai Wei, Zhou Jiangfeng, Ge Yuxi, Xie Zhihui, Jin Linfang, Pu Yong, Yan Gen. CT perfusion imaging of the stomach: a quantitative analysis according to different degrees of adenocarcinoma cell differentiation. Clinical Imaging 2016; 40(3): 558 doi: 10.1016/j.clinimag.2015.11.006
|
| 33 |
G Jomrich, SF Schoppmann. Targeting HER 2 and angiogenesis in gastric cancer. Expert Review of Anticancer Therapy 2016; 16(1): 111 doi: 10.1586/14737140.2016.1121110
|
| 34 |
Byung Woog Kang, Dakeun Lee, Ho Young Chung, Jae Ho Han, Young-Bae Kim. Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer. Journal of Cancer Research and Clinical Oncology 2013; 139(11): 1835 doi: 10.1007/s00432-013-1503-4
|
| 35 |
Maciej Ciesielski, Wiesław Janusz Kruszewski, Urszula Śmiałek, Jakub Walczak, Mariusz Szajewski, Jarosław Szefel, Jacek Wydra, Krzysztof Kawecki. The HER2 Gene and HER2 Protein Status and Chromosome 17 Polysomy in Gastric Cancer Cells in Own Material. Applied Immunohistochemistry & Molecular Morphology 2015; 23(2): 113 doi: 10.1097/PAI.0000000000000070
|
| 36 |
Zong-Qiong Sun, Gen Yan, Yu-Xi Ge, Jie Li, Lin-Fang Jin, Zhi-Hui Xie, Peng Zhao. Can low-dose CT perfusion imaging accurately assess response of advanced gastric cancer with neoadjuvant chemotherapy?. Journal of X-Ray Science and Technology 2017; 25(6): 981 doi: 10.3233/XST-17271
|
| 37 |
Azza Abdel-Aziz, Rehab Allah Ahmed, Afaf Taha Ibrahiem. Expression of pRb, Ki67 and HER 2/neu in gastric carcinomas: Relation to different histopathological grades and stages. Annals of Diagnostic Pathology 2017; 30: 1 doi: 10.1016/j.anndiagpath.2017.05.003
|
| 38 |
Hao Wu, Zhenzhai Cai, Guangrong Lu, Shuguang Cao, He Huang, Yi Jiang, Weijian Sun. Impact of c-erbB-2 Protein on 5-year Survival Rate of Gastric Cancer Patients after Surgery: A Cohort Study and Meta-analysis. Tumori Journal 2017; 103(3): 249 doi: 10.5301/tj.5000444
|
| 39 |
Ling Shan, Jianming Ying, Ning Lu. HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction adenocarcinoma in a Chinese population. Diagnostic Pathology 2013; 8(1) doi: 10.1186/1746-1596-8-76
|
| 40 |
Hiroshi Yoshida, Noriko Yamamoto, Hirokazu Taniguchi, Ichiro Oda, Hitoshi Katai, Ryoji Kushima, Hitoshi Tsuda. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma. Virchows Archiv 2014; 465(2): 145 doi: 10.1007/s00428-014-1597-3
|
| 41 |
D. Santini, B. Vincenzi, F. Pantano, G. Schiavon, G. Tonini. ‘All action no talk’: the role of HER2/neu in adjuvant therapy choice for gastric cancer. Annals of Oncology 2013; 24(7): 1715 doi: 10.1093/annonc/mdt172
|
| 42 |
Narikazu Boku. HER2-positive gastric cancer. Gastric Cancer 2014; 17(1): 1 doi: 10.1007/s10120-013-0252-z
|
| 43 |
Dang Anh Thu Phan, Vu Thien Nguyen, Thi Ngoc Ha Hua, Quoc Dat Ngo, Thi Phuong Thao Doan, Sao Trung Nguyen, Anh Tu Thai, Van Thanh Nguyen. HER2 Status and Its Heterogeneity in Gastric Carcinoma of Vietnamese Patient. Journal of Pathology and Translational Medicine 2017; 51(4): 396 doi: 10.4132/jptm.2017.04.24
|
| 44 |
Nick Baniak, Jenna-Lynn Senger, Shahid Ahmed, S. C. Kanthan, Rani Kanthan. Gastric biomarkers: a global review. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-0969-3
|
| 45 |
Huiying Sun, Rui Zhou, Yannan Zheng, Zhaowei Wen, Dingling Zhang, Dongqiang Zeng, Jianhua Wu, Zhenhua Huang, Xiaoxiang Rong, Na Huang, Li Sun, Jianping Bin, Yulin Liao, Min Shi, Wangjun Liao. CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy. Oncogene 2021; 40(34): 5342 doi: 10.1038/s41388-021-01932-0
|
| 46 |
Carolina Cruz-Reyes, Armando Gamboa-Dominguez. Her2 Amplification in Gastric Cancer Is a Rare Event Restricted to the Intestinal Phenotype. International Journal of Surgical Pathology 2013; 21(3): 240 doi: 10.1177/1066896913481055
|
| 47 |
Ali Zisan Genc, Resit Dogan Koseoglu, Akgul Arici, Osman Demir. HER-2/neu gene analysis on endoscopic biopsy samples and gastric resection materials in gastric carcinomas. Russian Open Medical Journal 2019; 8(4) doi: 10.15275/rusomj.2019.0410
|
| 48 |
Saba El-Gendi, Iman Talaat, Mona Abdel-Hadi. HER-2/Neu Status in Gastric Carcinomas in a Series of Egyptian Patients and Its Relation to Ki-67 Expression. Open Journal of Pathology 2015; 5(04): 101 doi: 10.4236/ojpathology.2015.54014
|
| 49 |
Yixing Jiang. Impact of Genetic Targets on Cancer Therapy. Advances in Experimental Medicine and Biology 2013; 779: 55 doi: 10.1007/978-1-4614-6176-0_3
|
| 50 |
Emel Ebru Pala, Umit Bayol, Alp Ozguzer, Ozlem Akman. HER2 status in gastric cancer: A comparison of two novel in situ hybridization methods (IQ FISH and dual color SISH) and two immunohistochemistry methods (A0485 and HercepTest™). Pathology - Research and Practice 2013; 209(9): 548 doi: 10.1016/j.prp.2013.05.008
|
| 51 |
Bo Wang, Ke Sun, Yinying Zou. Comparison of a Panel of Biomarkers Between Gastric Primary Cancer and the Paired Krukenberg Tumor. Applied Immunohistochemistry & Molecular Morphology 2017; 25(9): 639 doi: 10.1097/PAI.0000000000000347
|
| 52 |
Eduardo Henrique Cunha Neves Filho, Adriana Pinheiro Bezerra Pires, Rosane Oliveira de Sant'Ana, Silvia Helena Barem Rabenhorst, Carlos Gustavo Hirth, Maria Do Perpétuo Socorro Saldanha da Cunha. The association among HER2, MET and FOXP3 expression and tumor regression grading in gastric adenocarcinoma. APMIS 2018; 126(5): 389 doi: 10.1111/apm.12840
|
| 53 |
Sara D. Alharthi, Hemalatha Kanniyappan, Soundarya Prithweeraj, Divya Bijukumar, Mathew T. Mathew. Proteomic-based electrochemical non-invasive biosensor for early breast cancer diagnosis. International Journal of Biological Macromolecules 2023; 253: 126681 doi: 10.1016/j.ijbiomac.2023.126681
|
| 54 |
Shigehiro Koganemaru, Kohei Shitara. Antibody–drug conjugates to treat gastric cancer. Expert Opinion on Biological Therapy 2021; 21(7): 923 doi: 10.1080/14712598.2020.1802423
|
| 55 |
Carlos Gómez-Martin, Elena Garralda, M José Echarri, Anabel Ballesteros, Alberto Arcediano, José Luis Rodríguez-Peralto, Manuel Hidalgo, Fernando López-Ríos. HER2/neutesting for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer. Journal of Clinical Pathology 2012; 65(8): 751 doi: 10.1136/jclinpath-2012-200774
|
| 56 |
Junhun Cho, Jiyun Jeong, Jiyoun Sung, Chang Ohk Sung, Kyoung-Mee Kim, Cheol Keun Park, Min Gew Choi, Tae Sung Sohn, Jae Moon Bae, Sung Kim. A Large Cohort of Consecutive Patients Confirmed Frequent HER2 Positivity in Gastric Carcinomas with Advanced Stages. Annals of Surgical Oncology 2013; 20(S3): 477 doi: 10.1245/s10434-012-2818-0
|
| 57 |
Takahiro Ishii, Kohei Shitara. Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancer. Expert Review of Anticancer Therapy 2021; 21(11): 1193 doi: 10.1080/14737140.2021.1982698
|
| 58 |
Rui Li, Jing Li, Xiaopeng Wang, Pan Liang, Jianbo Gao. Detection of gastric cancer and its histological type based on iodine concentration in spectral CT. Cancer Imaging 2018; 18(1) doi: 10.1186/s40644-018-0176-2
|